AJANTA PHARMA Surges by 5%; BSE HEALTHCARE Index Up 3.1%

Wed, 15 Apr 10 am

AJANTA PHARMA share price has zoomed 5% and is presently trading at Rs 1,447.

Meanwhile, the BSE HEALTHCARE Index is at 15,250 (up 3.1%).

Among the top Gainers in the BSE HEALTHCARE Index today are AJANTA PHARMA (up 5.1%) and AUROBINDO PHARMA (up 6.3%).

ABBOTT INDIA (down 0.3%) and IPCA LABS (down 0.7%) are among the top losers today.

Over the last one year, AJANTA PHARMA has moved up from Rs 1,026 to Rs 1,447, registering a gain of Rs 421 (up 41.1%).

On the other hand, the BSE HEALTHCARE has moved up from 14,506 to 15,250, registering a gain of 744 points (up 5.0%) during the last 12 months.

The top gainers among the BSE HEALTHCARE Index stocks during this same period were ABBOTT INDIA (up 119.5%), IPCA LABS (up 63.1%) and ALKEM LABORATORIES (up 55.8%).

REVEALED: The Secret to potentially Making Rs 18,870, Rs 9,425 and Rs 7,315 in a Single Day...

What About the Benchmark Indices?

The BSE Sensex is at 31,400 (up 2.2%).

The top gainers among the BSE Sensex stocks today are AXIS BANK (up 5.2%), SUN PHARMA (up 5.2%) and INDUSIND BANK (up 4.6%). Other gainers include HUL (up 4.4%) and L&T (up 3.8%). The most traded stocks in the BSE Sensex are SBI and ONGC.

In the meantime, NSE Nifty is at 9,219 (up 2.5%). The top gainers in the NSE Nifty include UPL (up 11.5%), INDUSIND BANK (up 6.5%) and AXIS BANK (up 5.6%). Other gainers include SUN PHARMA (up 5.3%) and HUL (up 4.7%) are among the top gainers in NSE Nifty.

Over the last 12 months, the BSE Sensex has moved down from 38,906 to 31,400, registering a loss of 7,506 points (down 19.38%).

AJANTA PHARMA Financial Update...

AJANTA PHARMA net profit stood at Rs 1 billion for the quarter ended December 2019, compared to a profit of Rs 669 million a year ago. Net Sales rose 34.2% to Rs 6.5 billion during the period as against Rs 4.9 billion in October-December 2018.

For the year ended March 2019, AJANTA PHARMA reported 17.4% decrease in net profit to Rs 3.9 billion compared to net profit of Rs 4.7 billion during FY18.

Revenue of the company grew 3.5% to Rs 21 billion during FY19.

The current Price to earnings ratio of AJANTA PHARMA, based on rolling 12 month earnings, stands at 29.8x.

Indian Share Market Update: Top Gainers and Losers

What else is happening in the markets today? Dig in...